SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is experiencing significant volatility driven by the combination of reported engineering delays for its foldable iPhone and an ongoing patent infringement legal battle with Xiao-I Corp, which recently saw a court ruling in favor of the smaller firm. Community sentiment remains polarized, as bulls view the sell-off as a temporary reaction to minor news or a broader market correction, while bears highlight concerns over slowing innovation and potential settlement payouts.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is facing intense downward pressure driven by a bearish JPMorgan analyst downgrade and broader geopolitical uncertainty, fueling widespread investor debate over whether the stock is a falling knife or a long-term value play. The community is actively weighing the potential impact of a rumored SpaceX IPO, which many fear may siphon liquidity away from Tesla shares as investors rotate their capital into the upcoming space venture.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is seeing significant momentum as the CMS finalized 2027 Medicare Advantage payment rates at a 2.5% increase, coming in notably higher than market expectations. While bulls view this as a vital relief rally and a potential short squeeze catalyst, the community remains actively divided between those highlighting the company's long-term franchise strength and others concerned about ongoing regulatory pressure and utilization headwinds.

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group is experiencing a volatile surge driven by high short interest and speculative retail interest, which has fueled a rapid short squeeze. While community members debate whether this is a sustainable recovery or an overextended rally, trading activity remains intense as participants monitor the impact of broader industry dynamics and high-stakes options flow.

Hertz Global Holdings, Inc. engages in the vehicle rental business through the Hertz, Dollar, and Thrifty brands. It operates under the Americas Rental Car (RAC) and International Rental Car (RAC) segments. The Americas RAC segment focuses on operations in the United States, Canada, Latin America, and the Caribbean. The International RAC segment includes the provision of rental and sales of vehicles and value-added services in other locations. The company was founded in 1918 and is headquartered in Estero, FL.

Hertz Global Holdings Inc. - Ordinary Shares (New)

Hertz Global Holdings Inc

Hertz is seeing heightened community discussion driven by its heavy short interest and speculative potential for a short squeeze, with traders closely monitoring its correlation to Avis and the influence of Bill Ackman's stake. Investors are analyzing the stock's consolidation patterns while debating whether upcoming earnings and broader travel demand trends will provide the necessary catalyst for a significant price breakout.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Donald Trumps recent social media threats regarding potential military action against Iran have sparked intense controversy, with community members actively debating whether these statements signal a serious escalation or tactical posturing. Discussions on the platform are highly polarized, ranging from severe criticism over the potential for war crimes and humanitarian consequences to fervent support for the administration's aggressive negotiation style.

Mega Fortune Co., Ltd. operates as a holding company which provides information technology services. It specializes in delivering comprehensive IoT solutions and services across various industries. The firm offers low carbon property management, energy, stock and GreenTech management services. The company was founded in 2011 and is headquartered in Hong Kong.

Mega Fortune Co Ltd.

Mega Fortune Company Limited

Mega Fortune Company Limited is seeing significant retail interest driven by its status as a low-float, recent Chinese IPO, with traders aggressively comparing it to previous explosive market runners. The community is actively debating the stock's potential for rapid, sentiment-fueled volatility while many remain cautious of its history of sharp price reversals and pump-and-dump characteristics.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is experiencing significant market interest driven by mixed reactions to Lyme disease vaccine trial data and ongoing investor focus on the company's oncology pipeline and strategic cost-cutting measures. Community sentiment remains highly polarized, with active discussions centering on the company's ability to drive growth through M&A, the impact of patent cliffs, and skepticism regarding its recent market performance compared to peers.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is currently trending due to intense investor frustration and bearish sentiment surrounding its recent stock performance, with many questioning the leadership's strategy amid missed opportunities in the broader tech rally. While the community is actively debating the company's long-term potential in AI-driven edge computing and automotive growth against ongoing headwinds like memory supply shortages and competitive pressures from Apple, sentiment remains heavily divided between those seeking a turnaround entry point and those calling the stock dead money.

Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.

Axon Enterprise Inc

Axon Enterprise is experiencing significant downward volatility and price compression despite new product announcements, leading the community to intensely debate whether the current valuation is a bargain for long-term accumulation or a continued liquidity trap. Investors are focused on the upcoming earnings report and the broader sell-off in software-oriented stocks, with many highlighting concerns over persistent insider selling and a high valuation multiple.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Bicara Therapeutics (NASDAQ:BCAX) Sets New 12-Month High - Here's Why

Bicara Therapeutics (NASDAQ:BCAX) Sets New 52-Week High - Time to Buy...

HC Wainwright Has Bullish Estimate for BCAX Q1 Earnings

Bicara Therapeutics Inc. (NASDAQ:BCAX - Free Report) - Analysts at HC Wainwright boosted their Q1 2026 earnings per share estimates for Bicara Therapeutics in a research report issued on Tuesday...

Bicara Therapeutics (NASDAQ:BCAX) Hits New 1-Year High Following Analyst Upgrade

Bicara Therapeutics (NASDAQ:BCAX) Sets New 12-Month High on Analyst Upgrade...

Wall Street Analysts Believe Bicara Therapeutics Inc. (BCAX) Could Rally 54.85%: Here's is How to Trade

The average of price targets set by Wall Street analysts indicates a potential upside of 54.9% in Bicara Therapeutics Inc. (BCAX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Is CareCloud (CCLD) Stock Outpacing Its Medical Peers This Year?

Here is how CareCloud, Inc. (CCLD) and Bicara Therapeutics Inc. (BCAX) have performed compared to their sector so far this year.

Bicara Therapeutics (NASDAQ:BCAX) Price Target Raised to $16.00 at The Goldman Sachs Group

The Goldman Sachs Group increased their target price on Bicara Therapeutics from $14.00 to $16.00 and gave the company a "neutral" rating in a research note on Tuesday...

Bicara Therapeutics (NASDAQ:BCAX) Given "Outperform" Rating at Wedbush

Wedbush reiterated an "outperform" rating and set a $30.00 price objective on shares of Bicara Therapeutics in a research report on Tuesday...

Bicara Therapeutics (NASDAQ:BCAX) Price Target Raised to $16.00 at Wells Fargo & Company

Wells Fargo & Company upped their price target on shares of Bicara Therapeutics from $11.00 to $16.00 and gave the stock an "equal weight" rating in a research report on Tuesday...

Citizens Jmp Reiterates "Market Outperform" Rating for Bicara Therapeutics (NASDAQ:BCAX)

Citizens Jmp restated a "market outperform" rating and issued a $31.00 price objective on shares of Bicara Therapeutics in a research note on Tuesday...

Bicara Therapeutics To Rally Around 121%? Here Are 10 Top Analyst Forecasts For Tuesday

Top analysts changed outlook on top names. See all changes on analyst ratings page. BTIG & HCW cut price targets, Needham & BMO raised, Baird bcut.read more...

Bicara Therapeutics, Inc. is a clinical-stage biotechnology company and develops biologics engineered to combine the precision of well validated, tumor-targeting antibodies with the power of tumor microenvironment modulators. The company’s bi-functional antibodies are designed to deliver an immunomodulatory payload directly to the tumor microenvironment to ramp up immune cell activity, offering the potential for synergistic therapeutic impact at the site of the tumor. Its products include BCA101, a first-in-class EGFR/TGF-ß-trap bifunctional antibody in clinical development for multiple tumor types. The company was founded on December 12, 2018 and is headquartered in Boston, MA.

BCAX
Bicara Therapeutics

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest BCAX News

BCAXBicara Therapeutics